Back to Search
Start Over
Trial watch: Phase III promise for oral multiple sclerosis therapy.
- Source :
-
Nature reviews. Drug discovery [Nat Rev Drug Discov] 2009 Feb; Vol. 8 (2), pp. 98. - Publication Year :
- 2009
- Subjects :
- Administration, Oral
Clinical Trials, Phase III as Topic
Double-Blind Method
Fingolimod Hydrochloride
Humans
Immunosuppressive Agents administration & dosage
Immunosuppressive Agents adverse effects
Propylene Glycols administration & dosage
Propylene Glycols adverse effects
Randomized Controlled Trials as Topic
Sphingosine administration & dosage
Sphingosine adverse effects
Sphingosine therapeutic use
Immunosuppressive Agents therapeutic use
Multiple Sclerosis drug therapy
Propylene Glycols therapeutic use
Sphingosine analogs & derivatives
Subjects
Details
- Language :
- English
- ISSN :
- 1474-1784
- Volume :
- 8
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- Nature reviews. Drug discovery
- Publication Type :
- Periodical
- Accession number :
- 19180099
- Full Text :
- https://doi.org/10.1038/nrd2821